Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank 指定難病告示番号
1 CSF1R 3件: Ras signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Transcriptional misregulation in cancer D08552 Sunitinib 2件: 28, 34
2 CSF1R 3件: Ras signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Transcriptional misregulation in cancer D11270 Pexidartinib 1件: 34
3 EGFR 4件: Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis D01977 Gefitinib 1件: 75
4 EGFR 4件: Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis D03455 Cetuximab 2件: 51, 86
5 EGFR 4件: Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis D07907 Erlotinib 1件: 94
6 EGFR 4件: Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis D08108 Lapatinib 3件: 34, 74, 75
7 EGFR 4件: Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis D08950 Neratinib 1件: 34
8 EGFR 4件: Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis D11251 Icotinib 1件: 34
9 EGFR 4件: Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis D11772 Tesevatinib 1件: 67
10 EPHA2 1件: Ras signaling pathway D03658 Dasatinib 2件: 51, 85
11 EPHA2 1件: Ras signaling pathway D06414 Dasatinib 2件: 51, 85
12 FGFR1 4件: Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton D10481 Nintedanib 5件: 51, 85, 89, 227, 228
13 FGFR1 4件: Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton D11589 Infigratinib 1件: 276
14 FGFR3 3件: Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton D10481 Nintedanib 5件: 51, 85, 89, 227, 228
15 FGFR3 3件: Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton D11589 Infigratinib 1件: 276
16 FGFR2 3件: Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton D05338 Palifermin 5件: 13, 36, 38, 39, 65
17 FGFR2 3件: Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton D10481 Nintedanib 5件: 51, 85, 89, 227, 228
18 FGFR2 3件: Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton D11589 Infigratinib 1件: 276
19 FLT1 3件: Ras signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis D03218 Axitinib 1件: 34
20 FLT1 3件: Ras signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis D08552 Sunitinib 2件: 28, 34
21 FLT1 3件: Ras signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis D08881 Cediranib 1件: 34
22 FLT1 3件: Ras signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis D10481 Nintedanib 5件: 51, 85, 89, 227, 228
23 FLT3 2件: Ras signaling pathway, Transcriptional misregulation in cancer D08524 Sorafenib 2件: 34, 86
24 FLT3 2件: Ras signaling pathway, Transcriptional misregulation in cancer D08552 Sunitinib 2件: 28, 34
25 FLT3 2件: Ras signaling pathway, Transcriptional misregulation in cancer D11270 Pexidartinib 1件: 34
26 FLT4 1件: Ras signaling pathway D03218 Axitinib 1件: 34
27 FLT4 1件: Ras signaling pathway D08524 Sorafenib 2件: 34, 86
28 FLT4 1件: Ras signaling pathway D08552 Sunitinib 2件: 28, 34
29 FLT4 1件: Ras signaling pathway D08881 Cediranib 1件: 34
30 FLT4 1件: Ras signaling pathway D10481 Nintedanib 5件: 51, 85, 89, 227, 228
31 FLT4 1件: Ras signaling pathway D11772 Tesevatinib 1件: 67
32 ABL1 2件: Ras signaling pathway, Viral myocarditis D03252 Bosutinib 2件: 2, 67
33 ABL1 2件: Ras signaling pathway, Viral myocarditis D03658 Dasatinib 2件: 51, 85
34 ABL1 2件: Ras signaling pathway, Viral myocarditis D06414 Dasatinib 2件: 51, 85
35 ABL1 2件: Ras signaling pathway, Viral myocarditis D08066 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
36 ABL1 2件: Ras signaling pathway, Viral myocarditis D08953 Nilotinib 5件: 6, 8, 34, 51, 86
37 ABL1 2件: Ras signaling pathway, Viral myocarditis D09664 Saracatinib 3件: 6, 89, 272
38 GRIN1 2件: Ras signaling pathway, Spinocerebellar ataxia D00775 Riluzole 9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
39 GRIN1 2件: Ras signaling pathway, Spinocerebellar ataxia D03742 Dextromethorphan 11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
40 GRIN1 2件: Ras signaling pathway, Spinocerebellar ataxia D07058 Acamprosate 2件: 6, 206
41 GRIN1 2件: Ras signaling pathway, Spinocerebellar ataxia D07283 Esketamine 3件: 2, 4, 70
42 GRIN1 2件: Ras signaling pathway, Spinocerebellar ataxia D07441 Amantadine 4件: 6, 8, 13, 127
43 GRIN1 2件: Ras signaling pathway, Spinocerebellar ataxia D08098 Ketamine 8件: 2, 4, 6, 13, 70, 113, 156, 215
44 GRIN1 2件: Ras signaling pathway, Spinocerebellar ataxia D08174 Memantine 8件: 2, 6, 8, 13, 49, 127, 205, 206
45 GRIN1 2件: Ras signaling pathway, Spinocerebellar ataxia D09917 Latrepirdine 1件: 8
46 GRIN2A 3件: Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D00775 Riluzole 9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
47 GRIN2A 3件: Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D03742 Dextromethorphan 11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
48 GRIN2A 3件: Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D07058 Acamprosate 2件: 6, 206
49 GRIN2A 3件: Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D07283 Esketamine 3件: 2, 4, 70
50 GRIN2A 3件: Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D07441 Amantadine 4件: 6, 8, 13, 127
51 GRIN2A 3件: Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D08098 Ketamine 8件: 2, 4, 6, 13, 70, 113, 156, 215
52 GRIN2A 3件: Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D08174 Memantine 8件: 2, 6, 8, 13, 49, 127, 205, 206
53 GRIN2A 3件: Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D09917 Latrepirdine 1件: 8
54 GRIN2B 3件: Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D00775 Riluzole 9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
55 GRIN2B 3件: Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D03742 Dextromethorphan 11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
56 GRIN2B 3件: Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D07058 Acamprosate 2件: 6, 206
57 GRIN2B 3件: Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D07283 Esketamine 3件: 2, 4, 70
58 GRIN2B 3件: Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D07441 Amantadine 4件: 6, 8, 13, 127
59 GRIN2B 3件: Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D08098 Ketamine 8件: 2, 4, 6, 13, 70, 113, 156, 215
60 GRIN2B 3件: Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D08174 Memantine 8件: 2, 6, 8, 13, 49, 127, 205, 206
61 GRIN2B 3件: Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D09917 Latrepirdine 1件: 8
62 IGF1R 3件: Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer D03297 Mecasermin 6件: 65, 78, 96, 168, 265, 299
63 IGF1R 3件: Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer D09680 Teprotumumab 1件: 51
64 IGF1R 3件: Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer D09925 Linsitinib 1件: 232
65 INSR 3件: Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus D03230 Insulin human 2件: 96, 156
66 INSR 3件: Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus D03250 Insulin glargine 1件: 299
67 INSR 3件: Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus D04539 Insulin detemir 1件: 299
68 KDR 2件: Ras signaling pathway, VEGF signaling pathway D03218 Axitinib 1件: 34
69 KDR 2件: Ras signaling pathway, VEGF signaling pathway D08524 Sorafenib 2件: 34, 86
70 KDR 2件: Ras signaling pathway, VEGF signaling pathway D08552 Sunitinib 2件: 28, 34
71 KDR 2件: Ras signaling pathway, VEGF signaling pathway D08881 Cediranib 1件: 34
72 KDR 2件: Ras signaling pathway, VEGF signaling pathway D10062 Cabozantinib 1件: 34
73 KDR 2件: Ras signaling pathway, VEGF signaling pathway D10481 Nintedanib 5件: 51, 85, 89, 227, 228
74 KDR 2件: Ras signaling pathway, VEGF signaling pathway D11772 Tesevatinib 1件: 67
75 KIT 1件: Ras signaling pathway D03658 Dasatinib 2件: 51, 85
76 KIT 1件: Ras signaling pathway D06414 Dasatinib 2件: 51, 85
77 KIT 1件: Ras signaling pathway D08066 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
78 KIT 1件: Ras signaling pathway D08524 Sorafenib 2件: 34, 86
79 KIT 1件: Ras signaling pathway D08552 Sunitinib 2件: 28, 34
80 KIT 1件: Ras signaling pathway D08953 Nilotinib 5件: 6, 8, 34, 51, 86
81 KIT 1件: Ras signaling pathway D10229 Masitinib 6件: 2, 5, 6, 13, 46, 96
82 KIT 1件: Ras signaling pathway D11270 Pexidartinib 1件: 34
83 MET 3件: Ras signaling pathway, Transcriptional misregulation in cancer, Renal cell carcinoma D10062 Cabozantinib 1件: 34
84 NFKB1 17件: Ras signaling pathway, Sphingolipid signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Relaxin signaling pathway, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Small cell lung cancer D01146 Iguratimod 5件: 46, 51, 53, 271, 300
85 NGF 1件: Ras signaling pathway D09387 Tanezumab 2件: 226, 298
86 NGFR 3件: Virion - Lyssavirus, Ras signaling pathway, Transcriptional misregulation in cancer D11028 Cenegermin 2件: 53, 90
87 PDGFRA 2件: Ras signaling pathway, Regulation of actin cytoskeleton D08066 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
88 PDGFRA 2件: Ras signaling pathway, Regulation of actin cytoskeleton D08552 Sunitinib 2件: 28, 34
89 PDGFRA 2件: Ras signaling pathway, Regulation of actin cytoskeleton D08953 Nilotinib 5件: 6, 8, 34, 51, 86
90 PDGFRA 2件: Ras signaling pathway, Regulation of actin cytoskeleton D10481 Nintedanib 5件: 51, 85, 89, 227, 228
91 PDGFRB 2件: Ras signaling pathway, Regulation of actin cytoskeleton D03658 Dasatinib 2件: 51, 85
92 PDGFRB 2件: Ras signaling pathway, Regulation of actin cytoskeleton D06414 Dasatinib 2件: 51, 85
93 PDGFRB 2件: Ras signaling pathway, Regulation of actin cytoskeleton D08524 Sorafenib 2件: 34, 86
94 PDGFRB 2件: Ras signaling pathway, Regulation of actin cytoskeleton D08552 Sunitinib 2件: 28, 34
95 PDGFRB 2件: Ras signaling pathway, Regulation of actin cytoskeleton D08953 Nilotinib 5件: 6, 8, 34, 51, 86
96 PDGFRB 2件: Ras signaling pathway, Regulation of actin cytoskeleton D10481 Nintedanib 5件: 51, 85, 89, 227, 228
97 PGF 1件: Ras signaling pathway D09574 Aflibercept 2件: 90, 166
98 PIK3CA 19件: Ras signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Renal cell carcinoma, Small cell lung cancer D11011 Alpelisib 1件: 138
99 PIK3CA 19件: Ras signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Renal cell carcinoma, Small cell lung cancer D11158 Leniolisib 2件: 53, 65
100 PIK3CB 19件: Ras signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Renal cell carcinoma, Small cell lung cancer D11158 Leniolisib 2件: 53, 65
101 PIK3CD 19件: Ras signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Renal cell carcinoma, Small cell lung cancer D11158 Leniolisib 2件: 53, 65
102 PIK3CD 19件: Ras signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Renal cell carcinoma, Small cell lung cancer D11437 Parsaclisib 3件: 35, 53, 61
103 PRKCB 11件: Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, VEGF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Salivary secretion, Spinocerebellar ataxia D11935 Enzastaurin 1件: 168
104 MAP2K1 16件: Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D09666 Selumetinib 1件: 34
105 MAP2K1 16件: Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D10175 Trametinib 4件: 2, 34, 279, 280
106 MAP2K1 16件: Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D10405 Cobimetinib 1件: 280
107 MAP2K1 16件: Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D10604 Binimetinib 1件: 34
108 MAP2K1 16件: Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D11675 Mirdametinib 1件: 34
109 MAP2K2 14件: Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D09666 Selumetinib 1件: 34
110 MAP2K2 14件: Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D10175 Trametinib 4件: 2, 34, 279, 280
111 MAP2K2 14件: Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D10405 Cobimetinib 1件: 280
112 MAP2K2 14件: Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D10604 Binimetinib 1件: 34
113 MAP2K2 14件: Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D11675 Mirdametinib 1件: 34
114 RAF1 13件: Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, T cell receptor signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Tuberculosis, Renal cell carcinoma D08524 Sorafenib 2件: 34, 86
115 RELA 17件: Ras signaling pathway, Sphingolipid signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Relaxin signaling pathway, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Small cell lung cancer D12181 Edasalonexent 1件: 113
116 VEGFA 5件: Ras signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis D05697 Ranibizumab 4件: 34, 166, 227, 301
117 VEGFA 5件: Ras signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis D06409 Bevacizumab 6件: 13, 34, 85, 87, 227, 280
118 VEGFA 5件: Ras signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis D09574 Aflibercept 2件: 90, 166
119 VEGFB 2件: Ras signaling pathway, Relaxin signaling pathway D09574 Aflibercept 2件: 90, 166
120 FGF23 2件: Ras signaling pathway, Regulation of actin cytoskeleton D10913 Burosumab 1件: 238